MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
Apollo Endosurgery DPO Ratio 2011-2026 | APEN
Annual DPO Ratio Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.6 | 53.8 | 67.7 | 144 | 202 | 272 | 74.4 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 272 | 53.8 | 125 |
Quarterly DPO Ratio Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 35 | - | 68.7 | - | 66.8 | 63.9 | 59.3 | - | 57.4 | 104 | 122 | - | 155 | 127 | 193 | - | 218 | 211 | 234 | - | 278 | 252 | 286 | - | 237 | 93.3 | 91.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 286 | 35 | 148 |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
Abiomed
ABMD
|
76.2 | - | - | $ 17.2 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
81.1 | $ 9.54 | 2.03 % | $ 685 M |  Israel |
 |
AxoGen
AXGN
|
79.6 | $ 32.81 | 5.67 % | $ 1.45 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
99.4 | $ 21.96 | 0.76 % | $ 3.14 B | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
40.1 | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
52.8 | $ 3.47 | -2.49 % | $ 120 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.75 | -0.79 % | $ 140 M |  France |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 323.35 | -0.66 % | $ 9.12 B | USA |
 |
Boston Scientific Corporation
BSX
|
66 | $ 98.56 | 0.8 % | $ 145 B | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 53.03 | 0.68 % | $ 7.9 K | USA |
 |
CONMED Corporation
CNMD
|
60.6 | $ 43.31 | -0.39 % | $ 1.34 B | USA |
 |
Abbott Laboratories
ABT
|
82.8 | $ 126.93 | -0.69 % | $ 221 B | USA |
 |
Cardiovascular Systems
CSII
|
81.8 | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
InMode Ltd.
INMD
|
65.1 | $ 15.62 | 0.36 % | $ 1.24 B | Israel |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
Eargo
EAR
|
124 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
47.8 | $ 29.03 | 2.25 % | $ 245 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Align Technology
ALGN
|
33.7 | $ 166.78 | -0.52 % | $ 12.5 B | USA |
 |
Accuray Incorporated
ARAY
|
49.2 | $ 0.88 | -1.53 % | $ 90.4 M | USA |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
25.8 | $ 15.3 | 0.22 % | $ 414 M | USA |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.55 | 0.03 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
23.2 | $ 90.47 | -3.03 % | $ 12.3 B | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 1.19 | 0.85 % | $ 19.2 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 13.05 | -0.61 % | $ 1 B | USA |
 |
IRadimed Corporation
IRMD
|
40.6 | $ 97.9 | -0.17 % | $ 1.24 B | USA |
 |
Aziyo Biologics
AZYO
|
48.8 | - | 1.37 % | $ 20.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
70.1 | $ 18.33 | -2.19 % | $ 423 M | USA |
 |
Establishment Labs Holdings
ESTA
|
279 | $ 69.6 | 0.4 % | $ 1.96 B |  Costa-rica |
 |
Invacare Corporation
IVC
|
75.6 | - | - | $ 24.7 M | USA |